About 200 reports

The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches...

  • Healthcare
  • Chronic Disease
  • United States
  • Hospital Admission
  • Chronic Disease Prevalence

U.S. Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Delivery Type (Web-based, Cloud-based, On-premise), By Component, By End Use, By Application, By Therapeutic Area, And Segment Forecasts, 2021 - 2028 U.S. Patient Engagement Solutions Market Growth & Trends The...

  • Healthcare
  • Chronic Disease
  • United States
  • Chronic Disease Prevalence

FIGURE ## GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH

  • Diabetes
  • Therapy
  • World
  • United States
  • Europe
  • North America
  • APAC
  • Health Expenditure
  • Diabetes Prevalence

##.## Growing prevalence of chronic diseases

  • Chronic Disease
  • Therapy
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Chronic Disease Prevalence
  • Diabetes Prevalence

##.## Rising prevalence of chronic diseases to drive the market growth

  • Chronic Disease
  • Pharmaceutical
  • Therapy
  • World
  • United States
  • Europe
  • North America
  • APAC
  • Health Expenditure
  • Drug Approval

##.## Growing prevalence of chronic diseases

  • Healthcare
  • Diabetes
  • Chronic Disease
  • Medical Device
  • World
  • Europe
  • United States
  • North America
  • Health Expenditure
  • Diabetes Prevalence

Drainage Consumables Market As per National Kidney Foundation Inc., in 2017, 500,000 patients in the U.S. underwent dialysis, 200,000 of whom had already received a kidney transplant previously. Moreover, 17.9 million people die of cardiovascular diseases every year, says the World Health Organization (WHO). As a result...

  • Chronic Disease
  • World
  • APAC
  • United States
  • Chronic Disease Prevalence

Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Delivery Type, By Component (Software, Services), By End Use, By Application, By Therapeutic Area, By Region, And Segment Forecasts, 2020 - 2027 The global patient engagement solutions market size is expected to reach USD 41.7 billion by 2027.,...

  • Healthcare
  • Chronic Disease
  • World
  • North America
  • United States
  • Chronic Disease Prevalence

Immunohistochemistry Market Size, Share & Trends Analysis Report By Product (Antibodies, Equipment, Reagents, Kits), By Application (Diagnostics, Drug Testing), By End Use, By Region, And Segment Forecasts, 2020 - 2027 The global immunohistochemistry market size is expected to reach a value of USD 3.2 billion by 2027,...

  • Chronic Disease
  • In Vitro Diagnostic Reagent
  • World
  • United States
  • APAC
  • Chronic Disease Prevalence
  • Hospital Number

Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Dimerix Ltd, H## 2020

  • Chronic Disease
  • Genitourinary System Disease
  • World
  • United States
  • North America
  • Drug Approval
  • Pharmaceutical Registrations

##.## High burden of chronic diseases to drive market growth in Italy

  • Specialty Hospital
  • Healthcare
  • Hospital
  • Diagnostics
  • Ambulatory Care
  • Chronic Disease
  • United States
  • APAC
  • Surgical Procedures Performed
  • Hospital Number

U.S. Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis,...

  • Chronic Pain
  • Analgesic
  • United States
  • Chronic Disease Prevalence
  • Surgical Procedures Performed

Abstract: - Global Chronic Kidney Disease (CKD) Drugs Market to Reach $15.7 Billion by 2027 - Amid the COVID-19 crisis, the global market for Chronic Kidney Disease (CKD) Drugs estimated at US$13.7 Billion in the year 2020, is projected to reach a revised size of US$15.7 Billion by 2027, growing at a CAGR of 1.9% over...

  • Chronic Disease
  • World
  • China
  • United States

Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, Glaxosmithkline, Pfizer, Boehringer Ingelheim, and F. Hoffmann-La Roche. The global protein inhibitors market is expected to grow from $56.97 billion in 2020 to $62.54 billion in 2021 at a compound annual growth rate (CAGR) of 9.8%....

  • Monoclonal Antibody
  • Chronic Disease
  • United States
  • Chronic Disease Prevalence

##.## Rising prevalence of chronic diseases to propel market growth

  • Cell Therapy
  • Biotechnology
  • Healthcare
  • Pharmaceutical
  • Biopharmaceutical
  • Drug Development
  • Chronic Disease
  • World
  • Europe
  • United States
  • North America
  • APAC
  • Cancer Incidence
  • Chronic Disease Prevalence

Lubricants Market Research Report: By Base Oil (Mineral Oil, Synthetic Oil, Bio-Based Oil), Product Type (Engine Oil, Transmission and Hydraulic Fluid Oil, Gear Oil, General Industrial Oil, Grease, Metalworking Oil, Process Oil), End User (Automotive and Other Transportation, Heavy Equipment, Food and Beverages, Metallurgy and Metalworking,...

  • Healthcare
  • Lubricants
  • Chronic Disease
  • World
  • United States
  • Health Expenditure
  • Medical Technology Density

Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-infective, Chemotherapy), By Region, And Segment Forecasts, 2021 - 2028 Home Infusion Therapy Market Growth & Trends The global home infusion therapy market...

  • Chronic Disease
  • Anti-Infective
  • Injectable Delivery
  • World
  • North America
  • United States
  • APAC
  • Chronic Disease Prevalence

Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, GlaxoSmithKline, Pfizer, Boehringer Ingelheim and F. Hoffmann-La Roche. The global protein inhibitors market is expected to decline from $59.66 billion in 2019 to $56.97 billion in 2020 at a compound annual growth rate (CAGR) of...

  • Monoclonal Antibody
  • Chronic Disease
  • United States
  • Chronic Disease Prevalence

Major players in the nanomedicine market are Pfizer Inc., Nanotherapeutics Inc., NanoViricides Inc, Arrowhead Research Inc., Celgene Corporation, Bio-Gate AG, Merck AG, Ablynx NV, F. Hoffmann-La Roche AG, Nanospectra Biosciences, GE Healthcare, Gilead Sciences Inc., Novartis AG, Amgen Inc., and Sanofi. The global nanomedicine market...

  • Nanotechnology
  • Chronic Disease
  • Biopharmaceutical
  • Infectious Disease
  • Nanoparticle
  • World
  • APAC
  • United States
  • Cancer Incidence
  • Nanotechnology Revenue

Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline (GSK), Novartis AG, and Novo Nordisk A/S. The global biosimilar therapeutic peptides market is expected to grow from $0.76 billion in 2020 to $0.87...

  • Biosimilar
  • Chronic Disease
  • Drug Development
  • Biotechnology
  • Therapy
  • World
  • United Kingdom
  • United States
  • Drug Approval
  • Biosimilar Sales

Healthcare Insurance Industry - Competitive Landscape of Private Players Three type of plans are generally available in the private healthcare insurance market — medical insurance, income protection, and disease insurance. Disease insurance provides coverage and benefits for certain types of diseases and conditions,...

  • Healthcare
  • Insurance
  • Health Insurance
  • Private Health Insurance
  • Chronic Disease
  • APAC
  • United States
  • Chronic Disease Prevalence
  • Health Expenditure

Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs and Promega Corporation. The global protein expression market is expected to grow from $2.01 billion in 2020 to $2.13 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The growth...

  • Pharmaceutical
  • Biopharmaceutical
  • Chronic Disease
  • Clinical Trial
  • Therapy
  • World
  • United States
  • Chronic Disease Prevalence
  • Biologics Approval

‘Chronic kidney disease (CKD)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Chronic kidney disease in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan. Chronic Kidney Disease (CKD) Understanding Chronic...

  • Chronic Disease
  • Epidemiology
  • United States
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom
  • World

Major players in the mobile imaging services market are Accurate Imaging Inc., Alliance HealthCare Services Inc., Axiom Mobile Imaging, Carestream Health, Center for Diagnostic Imaging Inc., Cobalt Health, DMS Health Technologies Inc., Front Range Mobile Imaging Inc., Imaging On Site Inc., InHealth Group Limited, Interim Diagnostic Imaging...

  • Diagnostic Imaging
  • Chronic Disease
  • World
  • United States
  • APAC
  • Chronic Disease Prevalence
  • Medical Technology Density

Major players in the electrosurgical devices market are Bovie Medical Corporation, Johnson & Johnson Private Limited, B. Braun Melsungen AG, Medtronic PLC, and Smith and Nephew. The global electrosurgical devices and equipment market is expected to grow from $2.69 billion in 2020 to $2.9 billion in 2021 at a compound annual growth rate...

  • Medical Device
  • Chronic Disease
  • Cancer
  • World
  • United States
  • European Economic Area
  • Medical Devices Sales

Major players in the wearable injectors market are Amgen, Becton, Dickinson and Co., Enable Injections, Insulet Corporation, Ypsomed, Medtronic, Tandem Diabetes Care, Valeritas, West Pharmaceutical Services,and Sensile Medical AG. The global wearable injectors market is expected to grow from $5.145 billion in 2020 to $5.709 billion...

  • Diabetes
  • Cardiovascular Disease
  • Chronic Disease
  • World
  • United States
  • Wearables Sales

Major players in the single-chamber prefilled syringes market are BD, Gerresheimer, Schott, Catalent, Nipro, Weigao, Stevanato, Baxter, Vetter Pharma, and Terumo. The global single-chamber prefilled syringes market is expected to grow from $4.41 billion in 2020 to $4.97 billion in 2021 at a compound annual growth rate (CAGR) of 12.7%....

  • Injectable Delivery
  • Chronic Disease
  • World
  • France
  • Germany
  • United States
  • APAC
  • Chronic Disease Prevalence
  • Cancer Incidence

Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Qiagen N.V., Genmark Diagnostics, Thermo Fisher Scientific Inc., General Electric Company (Ge...

  • Clinical Diagnostic
  • HIV AIDS
  • In Vitro Diagnostic Reagent
  • Chronic Disease
  • Infectious Disease
  • Drug Development
  • Molecular Diagnostics
  • APAC
  • World
  • China
  • South America
  • North America
  • South Korea
  • Australia
  • Japan
  • Middle East
  • Russia
  • United States
  • United Kingdom
  • Indonesia
  • Western Europe
  • France
  • Eastern Europe
  • Germany
  • India
  • Brazil

Biosimilars Market By Product (Recombinant Glycosylated Proteins [Monoclonal Antibodies, Erythropoietin, Follitropin], Recombinant Non-Glycosylated Proteins [Insulin, Recombinant Human Growth Hormone, Granulocyte-Colony Stimulating Factor, Interferons], Recombinant Peptides), By Technology (Monoclonal Antibody, Recombinant DNA, Bioassays,...

  • Protein Therapy
  • Chronic Disease
  • Monoclonal Antibody
  • Human Growth Hormone
  • World
  • Europe
  • North America
  • Latin America
  • United States
  • APAC
  • China
  • Chronic Disease Prevalence
  • Drug Approval

Abstract: Global Rheumatoid Arthritis Diagnosis Tests Market to Reach $766.7 Million by 2026 Rheumatoid Arthritis (RA), a chronic autoimmune disease, causes inflammation in the joints, muscles, connective tissues, fibrous tissues, and tendons causing pain and swelling. The disease is developed...

  • Healthcare
  • Arthritis
  • Autoimmune Disease
  • World
  • United States
  • Auto-Immune Diseases Prevalence
  • Health Expenditure